Examining patient preferences in the treatment of rheumatoid arthritis using a discrete-choice approach

BACKGROUND: Biological disease-modifying antirheumatic drugs (bDMARDs) used in second-line treatment of rheumatoid arthritis (RA) are administered parenterally. However, so-called targeted synthetic DMARDs (tsDMARDs) – developed more recently – offer alternative (ie, oral) administration forms in se...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Krüger, Klaus, Rellecke, Julian, Schiffner-Rohe, Julia, Behmer, Olaf, Schiffhorst, Guido, Nolting, Hans-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098563/
https://www.ncbi.nlm.nih.gov/pubmed/27843301
http://dx.doi.org/10.2147/PPA.S117774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098563/
https://www.ncbi.nlm.nih.gov/pubmed/27843301
http://dx.doi.org/10.2147/PPA.S117774

Ejemplares similares